Ronak Bhimani
Internal Medicine · Norristown, PANPI 1760899975
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $622,742 of the $623,141 with a category attached, or 99.9%. Kedplasma LLC accounts for 99.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $225,580, more than ten times the $121 reported in 2020. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $6847.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kedplasma LLC$623K
- Siemens Medical Solutions USA, Inc.$149
- AstraZeneca$121
- Johnson & Johnson$107
- Vapotherm Inc$21
What the payments were for
- Consulting fees$622,742100%
- Food & beverage$3990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kedplasma LLC | 83 | $622,742 |
| Siemens Medical Solutions USA, Inc. | 1 | $149 |
| AstraZeneca | 1 | $121 |
| Johnson & Johnson | 5 | $107 |
| Vapotherm Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$121
How this compares
$623,141 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $19,357 |
| XareltoRivaroxaban | 18 | $10,842 |
| JardianceEmpagliflozin | 18 | $6,931 |
| BrilintaTicagrelor | 12 | $5,303 |
| TradjentaLinagliptin | 13 | $3,411 |
| Atorvastatin Calcium | 170 | $1,716 |
| LantusInsulin Glargine,hum.Rec.Anlog | 19 | $1,344 |
| Divalproex Sodium | 24 | $1,159 |
| Buspirone Hcl | 24 | $817 |
| Gabapentin | 39 | $758 |
| ClopidogrelClopidogrel Bisulfate | 84 | $733 |
| Pantoprazole Sodium | 50 | $523 |
| Olanzapine | 17 | $420 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $406 |
| Oseltamivir Phosphate | 15 | $378 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $107 | $10,84218 claims |
| AstraZenecaBrilinta | $121 | $5,30312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Norristown
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
- Gerald BishopErie$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.